Mr. Alain Masson has served as Deputy Chief Executive Officer and Pharmacist Manager of Vetoquinol SA as of April 1, 2008. He is also Quality Director of the Group since 2008. He holds a Doctorate in Pharmacy from the Universite de FrancheComte and obtained a postgraduate degree in Industrial Pharmacy majoring in cosmetology, Lyon . He began his career in the pharmaceutical industry in 1988 at Vetoquinol Laboratories, as head of quality control. He has held the positions of Quality Assurance manager, Head of Quality and Group Industrial Quality Manager, France. Since 2008, he was in charge of the Group overall Quality at industrial sites, at the distribution subsidiaries and the R&D centers. He is Vice Chairman of GMP IFAH Europe.
Chief Pharmacist and Deputy CEO
Age: 50 CEO Since 2008 Ph.D
The company has return on total asset (ROA) of 5.97 % which means that it generated profit of $5.97 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.28 % meaning that it generated $10.28 on every $100 dollars invested by stockholders.
The company has accumulated 50.39 M in total debt with debt to equity ratio (D/E) of 0.22 which may suggest the company is not taking enough advantage from borrowing. V has Current Ratio of 2.06 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Entity SummaryV?toquinol S.A., a veterinary pharmaceutical laboratory, engages in the development, production, and marketing of veterinary medicines and nonmedicinal products. V [VETO] is traded on Paris Stock Exchange in France. It is located in Lure, and employs 1,812 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
V has less than 13.33 (%) percent chance of experiencing financial distress in the next 2 years of operations.
V price boundaries
Promote V and Alain Masson